<i>Drosophila</i> as a Model of Unconventional Translation in Spinocerebellar Ataxia Type 3

<i>Drosophila</i> as a Model of Unconventional Translation in Spinocerebellar Ataxia Type 3

RNA toxicity contributes to diseases caused by anomalous nucleotide repeat expansions. Recent work demonstrated RNA-based toxicity from repeat-associated, non-AUG-initiated translation (RAN translation). RAN translation occurs around long nucleotide repeats that form hairpin loops, allowing for tran...

Full description

Bibliographic Details
Main Authors:	Sean L. Johnson, Matthew V. Prifti, Alyson Sujkowski, Kozeta Libohova, Jessica R. Blount, Luke Hong, Wei-Ling Tsou, Sokol V. Todi
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Cells
Subjects:	ataxin-3 Gal4-UAS glia Machado–Joseph disease neuron neurodegeneration
Online Access:	https://www.mdpi.com/2073-4409/11/7/1223

Similar Items

Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics
by: Rodrigo Paulino, et al.
Published: (2023-04-01)

Nystagmus may be the first neurological sign in early stages of spinocerebellar ataxia type 3
by: Maria Thereza Drumond Gama, et al.
Published: (2021-01-01)

Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation
by: Sean L Johnson, et al.
Published: (2020-09-01)

Altered retinal structure and function in Spinocerebellar ataxia type 3
by: Vasileios Toulis, et al.
Published: (2022-08-01)

The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster
by: Wei-Ling Tsou, et al.
Published: (2015-10-01)

Regional and age-dependent changes in ubiquitination in cellular and mouse models of spinocerebellar ataxia type 3
by: Haiyang Luo, et al.
Published: (2023-04-01)

Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein
by: Naila S. Ashraf, et al.
Published: (2020-04-01)

Mitochondrial Dysfunction in Spinocerebellar Ataxia Type 3 Is Linked to VDAC1 Deubiquitination
by: Tina Harmuth, et al.
Published: (2022-05-01)

Endurance exercise ameliorates phenotypes in Drosophila models of spinocerebellar ataxias
by: Alyson Sujkowski, et al.
Published: (2022-02-01)

Polyglutamine length-dependent toxicity from α1ACT in Drosophila models of spinocerebellar ataxia type 6
by: Wei-Ling Tsou, et al.
Published: (2016-12-01)

A Difficult Case to Diagnose: Machado-Joseph Disease/Spinocerebellar Ataxia Type III
by: Muhammad Sohail Ajmal Ghoauri, et al.
Published: (2023-12-01)

Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in Drosophila models of Spinocerebellar Ataxia Type 3
by: Matthew V. Prifti, et al.
Published: (2023-01-01)

Itajaí, Santa Catarina – Azorean ancestry and spinocerebellar ataxia type 3
by: Hélio A. G. Teive, et al.

Clinical relevance of "bulging eyes" for the differential diagnosis of spinocerebellar ataxias
by: Adriana Moro, et al.
Published: (2013-07-01)

Machado-Joseph disease in Brazil: from the first descriptions to the emergence as the most common spinocerebellar ataxia
by: José Luiz Pedroso, et al.
Published: (2012-08-01)

Sodium valproate increases activity of the sirtuin pathway resulting in beneficial effects for spinocerebellar ataxia-3 in vivo
by: Maxinne Watchon, et al.
Published: (2021-08-01)

Assessment of Bone Mineral Density of Patients with Spinocerebellar Ataxia Type 3
by: Aline MS Farias, et al.
Published: (2019-01-01)

Ectoine alters subcellular localization of inclusions and reduces apoptotic cell death induced by the truncated Machado–Joseph disease gene product with an expanded polyglutamine stretch
by: Kentaro Furusho, et al.
Published: (2005-10-01)

Ataxin-3, The Spinocerebellar Ataxia Type 3 Neurodegenerative Disorder Protein, Affects Mast Cell Functions
by: Anna S. Sowa, et al.
Published: (2022-04-01)

Spinocerebellar ataxia type 3: subphenotypes in a cohort of brazilian patients
by: Adriana Moro, et al.
Published: (2014-09-01)

Recurrent divergence-insufficiency esotropia in Machado-Joseph disease (spinocerebellar ataxia type 3)
by: Jeannette Y. Stallworth, et al.
Published: (2022-12-01)

Molecular and cytological analysis of widely-used Gal4 driver lines for Drosophila neurobiology
by: Anna A. Ogienko, et al.
Published: (2020-10-01)

Ataxin-3 and its E3 partners: Implications for Machado-Joseph disease
by: Thomas M Durcan, et al.
Published: (2013-05-01)

Modest Reduction in CAG Repeat Length Rescues Motor Deficits but Not Purkinje Cell Pathology and Gliosis in Spinocerebellar Ataxia Type 1 Mice
by: Stephen Gilliat, et al.
Published: (2023-03-01)

Disease-associated oligodendrocyte signatures are spatiotemporally dysregulated in spinocerebellar ataxia type 3
by: Kristen H. Schuster, et al.
Published: (2023-02-01)

Research progress of miRNA and siRNA in spinocerebellar ataxia type 3
by: Feng-zhen HUANG, et al.
Published: (2013-08-01)

Occupational therapy in spinocerebellar ataxia type 3: an open-label trial
by: R.C.R. Silva, et al.
Published: (2010-06-01)

A Novel Calpain Inhibitor Compound Has Protective Effects on a Zebrafish Model of Spinocerebellar Ataxia Type 3
by: Katherine J. Robinson, et al.
Published: (2021-09-01)

Pathogenetic Mechanisms Underlying Spinocerebellar Ataxia Type 3 Are Altered in Primary Oligodendrocyte Culture
by: Kristen H. Schuster, et al.
Published: (2022-08-01)

Sleep Alterations in a Mouse Model of Spinocerebellar Ataxia Type 3
by: Maria-Efstratia Tsimpanouli, et al.
Published: (2022-10-01)

Neurodegenerative phosphoprotein signaling landscape in models of SCA3
by: Anna S. Sowa, et al.
Published: (2021-03-01)

An Optimal Ubiquitin-Proteasome Pathway in the Nervous System: The Role of Deubiquitinating Enzymes
by: Gorica eRistic, et al.
Published: (2014-08-01)

Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows Spinocerebellar ataxia type 1 phenotypes
by: Cristian A Lasagna-Reeves, et al.
Published: (2015-12-01)

Expanded ataxin-7 cause toxicity by inducing ROS production from NADPH oxidase complexes in a stable inducible Spinocerebellar ataxia type 7 (SCA7) model
by: Ajayi Abiodun, et al.
Published: (2012-07-01)

Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado–Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies
by: Yu-Shuan Chen, et al.
Published: (2020-04-01)

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
by: Adriano M. de Assis, et al.
Published: (2017-09-01)

Broad Influence of Mutant Ataxin-3 on the Proteome of the Adult Brain, Young Neurons, and Axons Reveals Central Molecular Processes and Biomarkers in SCA3/MJD Using Knock-In Mouse Model
by: Kalina Wiatr, et al.
Published: (2021-06-01)

The Natural History of Spinocerebellar Ataxia Type 3 in Mainland China: A 2-Year Cohort Study
by: Yun Peng, et al.
Published: (2022-07-01)

RNA Expression Profile and Potential Biomarkers in Patients With Spinocerebellar Ataxia Type 3 From Mainland China
by: Tianjiao Li, et al.
Published: (2019-06-01)

A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats
by: Jana Boy, et al.
Published: (2010-02-01)